4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000250
EVP Chief Commercial Officer sold 4,699 shares at $398.30 ($1,871,621)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-09-09 | Sale | −3,297 | $398.30 | $1,313,202 | 48,214 | D: show line 1 in the form |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-09-09 | Sale | −1,402 | $398.30 | $558,419 | 46,812 | D: show line 2 in the form |
| Open-market sales · 4,699 sh · avg $398.30 · $1,871,621 | |||||||
Loading xslF345X03/edgardoc.xml…